abstract |
Disclosed are proteins having antibody heavy chain variable domains and light chain variable domains that can be paired to form an antigen binding site targeting CD33 (Siglec-3) on cells, pharmaceutical compositions comprising the proteins, And methods of treatment using the proteins and pharmaceutical compositions, including methods of treatment for cancer. |